Assessment of Drug Related Problems in Patients with Cardiovascular Diseases in a Tertiary Care Teaching Hospital

  • Javedh Shareef Department of Pharmacy Practice, Nitte Gulabi Shetty Memorial Institute of Pharmaceutical Sciences, Deralakatte, Mangalore, Karnataka, India.
  • Sandeep B Department of Pharmacy Practice, Nitte Gulabi Shetty Memorial Institute of Pharmaceutical Sciences, Deralakatte, Mangalore, Karnataka, India.
  • C S Shastry NGSM Institute of Pharmaceutical Sciences, Deralakatte - 575018, Mangalore, Karnataka, India.
Keywords: Adverse Drug Events, Pharmacist, Cardiovascular Agents


Backgrounds: Drug related problems can be defined as any event (or) circumstance involving the drug treatment, which interferes or potentially interferes with the patient in achieving an optimum outcome of medical care. The aim of the study was to identify drug therapy problems and to assess the pharmacist interventions in patients with cardiovascular diseases.
Methods: The inpatient case records including drug history and other relevant details of the admitted patients under the cardiology department were collected and reviewed by the clinical pharmacist for drug related problems. In case if any drug related problem was identified, was discussed with the concerned physician and suitable interventions was provided and
Results: A total of 112 patient case sheets were reviewed during the study period, out of which 53 drug related problems were identified from 44 patients. The most common drug related problem was found to be drug Interactions (49.05%) followed by Adverse Drug Reaction (18.86%), and failure to receive drugs (9.43%). The most frequent suggestions provided by the intervening pharmacist were cessation of drug (24.52%), followed by Change in frequency of administration (22.64%), change in drug dose (20.75%). The majority of level of significance of drug related problems was seen to have moderate significance in grade. The acceptance rate of recommendations and change in drug therapy was found to be high (96.21%).
Conclusion: The current study highlights the importance of a pharmacist in a multidisciplinary team of routinely reviewing the drug therapy for identification and resolution of drug related problems which helps in achieving better therapeutic outcomes and improved patient care.


Preventing chronic disease: a vital investment. Geneva, World Health Organization, 2005.

The World Health Report 2002: reducing risks, promoting healthy life. Geneva, World Health Organization, 2002.

Berenson GS, Srinivasan SR, Hunter SM, et al. Risk factors in early life as predictors of adult heart disease: the Bogalusa Heart Study. Am J Med Sci 1989; 298(3):141–151.

Zieske AW, Malcom GT, Strong JP. Natural history and risk factors of atherosclerosis in children and youth: the PDAY study. Pediatr Pathol Mol Med 2002; 21(2):213–237.

Integrated management of cardiovascular risk: report of a WHO meeting. Geneva, World Health Organization, 2002.

Viktil KK, Blix HS. The Impact of Clinical Pharmacists on Drug-Related Problems and Clinical Outcomes. Basic Clin Pharmacol Toxicol 2008; 102(3):275-80.

Roberts MS, Stokes JA, King MA, et al. Outcomes of a randomized controlled trial of a clinical pharmacy intervention in 52 nursing homes. Br J Clin Pharmacol 2001; 51:257-265.

Blix HS, Viktil KK. The majority of hospitalised patients have drug-related problems: results from a prospective study in general hospitals. Eur J Clin Pharmacol 2004; 60:651–658.

Parthasarathi G, Ramesh M, Kumar JK, Madaki S. Assessment of Drug- Related Problems and Clinical Pharmacists’ Interventions in an Indian teaching hospital. J Pharm Pract Res 2003; 33:272-274.

Abraham RR, Manjula Devi AS. Drug Related Problems and Reactive Pharmacist Interventions for Inpatients Receiving Cardiovascular Drugs. Am J Pharm Tech Res 2012; 2(3): 2249-3387.

Celin AT, Seuma J, Ramesh A. Assessment of Drug Related Problems in Stroke Patients Admitted to a South Indian Tertiary Care Teaching Hospital. Indian J Pharm Pract 2012; 5(4):28–33.

Hepler CD, Strand LM. Opportunities and responsibilities in pharmaceutical care. Am J Hosp Pharm 1990; 47:533–43.

Kaboli PJ, Hoth AB, McClimon BJ, Schnipper JL. Clinical Pharmacist and Inpatient Medical Care Arch Inter Med 2006; 166:955-964. 14. Parthasarathi G, Ramesh M, Karin Nyfort-Hansen, Nagavi BG. Clinical Pharmacy in a South Indian teaching hospital. Ann Pharmacother 2002; 36(5):927-932.

Binu KM, Nimmy N John, Geo P Varghese. A survey of drug related problems identified by community pharmacy in south India. IJPCBS 2012; 2(2):369–74.

Ganachari MS, Mahendra Kumar BJ, Shashikala C Wali, Fibin M. Assessment of Drug Therapy Interventions by Clinical Pharmacist in a Tertiary Care Hospital. Indian J Pharm Pract 2010; 3 (3):22–28.

Alagiriswami B, Ramesh M, Parthasarathi G, Basavanagowdappa H. Clinical Pharmacist Initiated Changes in Drug Therapy in a Teaching Hospital. Indian J Pharm Pract 2009; 1(2): 36-45.

Satishkumar BP, Dahal P, Venkataraman R, Fuloria PC. Assessment of clinical pharmacist intervention in tertiary care teaching hospital of southern India. Asian J Pharm Clin Res 2013; 6(2): 258-261.

Vinks THA, Koning FHP, Lange TM, Egberts TCG. Identification of potential drug-related problems in the elderly: the role of the community pharmacist. Pharm World Sci 2006; 28:33–38

Jimmy OD, Shobha Rani RH, Indira R, Ramjan S. Study of Drug-drug Interactions in the Medication Charts in Medicine Wards at a Tertiary Care Hospital, Bangalore. IJPP 2012;5(4):61-4.

Kucukarslan SN, Peters M, Mlynarek M, Nafziger DA. Do pharmacists’ presence on rounding teams reduce preventable adverse drug events in hospital general medical units? Arch Intern Med 2003; 163:2014-8.

Mangasuli S, Padma GM Rao. Clinical interventions: A preliminary survey in a south Indian teaching hospital. Indian J Pharmacol 2006; 38 (5): 361-62.

How to Cite
Shareef J, B S, Shastry C. Assessment of Drug Related Problems in Patients with Cardiovascular Diseases in a Tertiary Care Teaching Hospital. J Pharm Care. 2(2):70-76.
Original Article(s)